The implications of particle size on ICS dose response in patients with asthma

The aim of the study was to evaluate the relationship between ICS dose and treatment outcomes for patients prescribed small / large particle formulation by comparing asthma control outcomes and treatment-related side effects associated with different doses of each ICS in order to create real-life dose-response curves.

Conducted by the Small Airways Study Group
Status: Active Study
Support: Teva
Documents and Publications:
Final Publications
Additional Material

Leave a Reply

Your email address will not be published. Required fields are marked *